Learning Center
Webinars
-
Contains 2 Component(s) Includes a Live Web Event on 12/11/2024 at 1:00 PM (EST)
This session will review the efficacy, safety, and administration of a potential treatment option for patients with cUTI and will describe the flexibility that this treatment option offers across sites of care within infusion services.
THIS WEBINAR IS A LIVE EVENT ONLY | DECEMBER 11 at 1pm ET
This session will review the efficacy, safety, and administration of a potential treatment option for patients with cUTI and will describe the flexibility that this treatment option offers across sites of care within infusion services.
Learning Objectives: At the conclusion of this session, learners will be able to:
- Understand the efficacy and safety profile of a potential treatment option for patients with cUTI
- Recognize the benefits of a treatment option for patients with cUTI across infusion services
- Explain the preparation and administration of a potential treatment option for patients with cUTI
Nikhil K. Bhayani, MD, FIDSA
Assistant Professor
Department of Internal Medicine, Anne Burnett Marion School of Medicine at Texas Christian University
Nikhil K. Bhayani, MD, FIDSA, is an esteemed physician with over 18 years of experience in internal medicine and infectious disease. He has made major contributions to clinical practice, medical education, and research that have garnered him acclaim, including being named the 2024 Physician of the Year by Texas Health Harris Methodist Alliance Hospital, being the recipient of the 2021 Albert Nelson Marquis Lifetime Achievement Award, and numerous accolades awarded by the International Association of Top Professionals.
Dr Bhayani is a graduate of the Ross University School of Medicine and holds a bachelor’s in biology from the University of Utah. He is currently an Assistant Professor at Anne Burnett Marion School of Medicine at Texas Christian University and an Infectious Diseases/Epidemiology Physician Advisor for the Department of Quality, Patient Safety, and Infection Prevention at Texas Health Resources, where he provides clinical guidance, supports quality improvement initiatives, and participates in multidisciplinary committees and projects. Dr Bhayani is deeply committed to improving health outcomes in the diverse patient population of the Dallas-Fort Worth area he serves, enhancing medical education, and contributing to the global fight against infectious diseases.-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Contains 3 Component(s), Includes Credits
This session will provide an overview of findings gleaned from a point prevalence study on PIVC placement and complications. Details regarding the study process and associated findings will be provided. Lessons learned and education and practice implications will also be explored.
This session will provide an overview of findings gleaned from a point prevalence study on PIVC placement and complications. Details regarding the study process and associated findings will be provided. Lessons learned and education and practice implications will also be explored.
Learning Objectives: At the conclusion of this session, learners will be able to:
● Describe the process for a point prevalence study
● Discuss common findings gleaned from the point prevalence study
● Identify recommended practices to improve PIVC documentation and complication recognition
Judy Smith, MSN, RN, CRNI®
Judy Smith, MSN, RN, CRNI®, serves as Director of Vascular Access and Wound Care for Ascension Seton in Austin, Texas. She completed her BSN at the University of Texas at Austin in 1995 and her MSN in Healthcare Systems Management at Loyola University New Orleans in 2010. She has worked in the Vascular Access specialty for 21 years and published 2 research studies on disinfection of needleless connectors and 1 point prevalence study related to PIVC complications and documentation. She has presented at many Vascular Access and Infusion Therapy conferences in the United States and New Zealand. Judy enjoys reading and spending time with her family, especially her 2 grandsons.
Vallire Hooper, PhD, RN, CPAN, FASPAN, FAAN
Vallire Hooper, PhD, RN, CPAN, FASPAN, FAAN, is a Senior Nurse Scientist with Ascension. She has been a nurse for over 35 years, with a primary focus in perianesthesia nursing, working as a staff nurse, Clinical Nurse Specialist, and lastly, as a Clinical Nurse Scientist for the last 14 years. Dr Hooper obtained her PhD in Nursing from the Medical College of Georgia in 2009, with a research focus on factors influencing the multidisciplinary adoption of evidence-based clinical practice guidelines. She is a Fellow in the American Society of PeriAnesthesia Nurses as well as the American Academy of Nursing. Dr Hooper’s primary research interests include clinically focused patient outcomes research and factors influencing nursing care delivery.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: November 20, 2027
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - $45
- Member - Free!
- More Information
-
Register
-
Contains 2 Component(s)
During the webinar, we will discuss unmet medical needs in the management of candidemia and invasive candidiasis, provide an overview of a next generation echinocandin, and review potential treatment scenarios and patient management considerations.
THIS WEBINAR IS A LIVE EVENT ONLY | NOVEMBER 12 at 1pm ET
During the webinar, we will discuss unmet medical needs in the management of candidemia and invasive candidiasis, provide an overview of a next generation echinocandin, and review potential treatment scenarios and patient management considerations.
Learning Objectives: At the conclusion of this session, learners will be able to:
- Discuss unmet medical needs in the management of candidemia and invasive candidiasis
- Provide an overview of a next-generation echinocandin
- Discuss potential treatment scenarios and patient management considerations
PP-REZ-US-0343
10/24
Yvonne J. Burnett, PharmD, BCIDP
Infectious Diseases Pharmacist and Regional Antimicrobial Stewardship Coordinator
Yvonne J. Burnett, PharmD, BCIDP is an Infectious Diseases Pharmacist and Regional Antimicrobial Stewardship Coordinator at SSM Health for St. Louis University Hospital and Cardinal Glennon in St. Louis, MO. Dr. Burnett obtained her Doctor of Pharmacy degree from The University of Rhode Island and pursued residency training back in her home state of NJ at Atlantic Health System for her PGY1 and then South Texas Veterans Health Care System/University of Texas Health Science Center in San Antonio, TX for her PGY2 in Infectious Diseases. Prior to her current role at SSM Health, Dr. Burnett worked as an Associate Professor of Pharmacy Practice at St. Louis College of Pharmacy and held clinical appointments, first with the Division of Infectious Diseases at Washington University in St. Louis, leading the outpatient parenteral antimicrobial therapy team and, then as an infectious diseases and antimicrobial stewardship pharmacist at Missouri Baptist Medical Center. Dr. Burnett is board certified in Infectious Diseases Pharmacotherapy and is an active member of Society of Infectious Diseases Pharmacists, Infectious Diseases Society of America, and the Missouri and St. Louis Societies of Health-System Pharmacists. Dr. Burnett's practice and research interests include antimicrobial stewardship, outpatient parenteral antimicrobial therapy, and medical/pharmacy education and precepting. Outside of work, she enjoys traveling with friends, trying out the many great bars and restaurants St. Louis has to offer, and keeping up with her middle schooler and black Labrador.
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Contains 3 Component(s), Includes Credits Recorded On: 09/18/2024
The treatment of an extravasation, the inadvertent delivery of a vesicant into the tissue around a vascular access device (VAD), is a source of patient harm that is under-recognized, under-reported, and thus likely ineffectively treated. Unfortunately, recommendations for extravasation treatment (primarily reliant on case reports) can be difficult to leverage into clear clinical guidelines, increasing the risk of inadequate or delayed post-extravasation monitoring and treatment. This presentation will review vesicant properties and their mechanisms of tissue injury, peripheral vs central VAD extravasation risks with related prevention measures, and recommended extravasation treatment strategies and resources using a case study approach.
The treatment of an extravasation, the inadvertent delivery of a vesicant into the tissue around a vascular access device (VAD), is a source of patient harm that is under-recognized, under-reported, and thus likely ineffectively treated. Unfortunately, recommendations for extravasation treatment (primarily reliant on case reports) can be difficult to leverage into clear clinical guidelines, increasing the risk of inadequate or delayed post-extravasation monitoring and treatment. This presentation will review vesicant properties and their mechanisms of tissue injury, peripheral vs central VAD extravasation risks with related prevention measures, and recommended extravasation treatment strategies and resources using a case study approach.
Objectives:
- Describe the properties of the major vesicant categories that may precipitate tissue injury
- Relate the relative extravasation risks of peripheral vs central VADS to extravasation prevention strategies
- Describe current recommendations for treatment of selected vesicant extravasations, using a case study approach
Barb Nickel, APRN-CNS, CCRN, CRNI®
Barb Nickel, APRN-CNS, CCRN, CRNI®, is a Clinical Nurse Specialist, specializing in critical care and vascular access. Her role includes staff development, quality improvement, and clinical consultation. She has presented nationally and published on infusion therapy. She was chair of the 2024 INS Standards of Practice Committee and is chair of the newly forming 2027 Standards of Practice Committee.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: September 18, 2027
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - $45
- Member - Free!
- More Information
-
Contains 3 Component(s), Includes Credits Recorded On: 08/21/2024
The need for alternate sites of care for oncology patients is growing with the expansion of the biologic drug portfolio. Insurance companies are shifting patients from hospital sites of service to independent providers, and the home and ambulatory clinic settings are now an attractive option for patients seeking more convenient sites for their infusions. In this session, we will outline the framework necessary to design an oncology infusion program, the policies and procedures necessary, and components of training needed to meet the challenges that serving this population of patients brings.
The need for alternate sites of care for oncology patients is growing with the expansion of the biologic drug portfolio. Insurance companies are shifting patients from hospital sites of service to independent providers, and the home and ambulatory clinic settings are now an attractive option for patients seeking more convenient sites for their infusions. In this session, we will outline the framework necessary to design an oncology infusion program, the policies and procedures necessary, and components of training needed to meet the challenges that serving this population of patients brings.
Learning Objectives: At the conclusion of this session, learners will be able to:
• list the critical components necessary to provide safe infusion care for the oncology population
• discuss the process used to determine medications’ appropriateness in the alternate infusion setting
• describe key points for a training program to be used for nurses in the expansion of their skillset to include oncology
• define effective communication methods and patterns to support the administration of oncology therapies in a setting outside of hospital outpatient facilities or physician office.
Pamela Jones McIntyre, MSN, RN, CRNI®, IgCN, OCN, VA-BC
Pamela Jones McIntyre, MSN, RN, CRNI®, IgCN, OCN, VA-BC, has over 4 decades of comprehensive nursing experience. She is considered a subject matter expert in infusion therapy, with extensive experience operating ambulatory infusion clinics for specialty and oncology therapies, and 24 years of experience as an operator and Vice President of Clinical Services for home infusion. Recent projects have focused on expanding oncology biologic therapies to alternate sites of infusion, which Ms. McIntyre is determined to see accomplished safely and in the best interest of the patients and providers. She provides consulting services to health care organizations for infusion nursing program development and newly established ambulatory infusion centers through her LLC, Expert Infusion Nurse Consulting.
CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: August 21, 2027
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.
-
Register
- Non-member - $45
- Member - Free!
- More Information
-
Register